These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 1065215
1. Management of hallucinogen abuse. Haddad LM. Am Fam Physician; 1976 Jul; 14(1):82-7. PubMed ID: 1065215 [Abstract] [Full Text] [Related]
2. The hallucinogens and the inhalants. Cohen S. Psychiatr Clin North Am; 1984 Dec; 7(4):681-8. PubMed ID: 6097885 [Abstract] [Full Text] [Related]
3. PATTERNS OF HALLUCINOGENIC DRUG ABUSE. LUDWIG AM, LEVINE J. JAMA; 1965 Jan 11; 191():92-6. PubMed ID: 14233246 [No Abstract] [Full Text] [Related]
4. Contemporary drugs of abuse. Giannini AJ, Price WA, Giannini MC. Am Fam Physician; 1986 Mar 11; 33(3):207-16. PubMed ID: 2869670 [Abstract] [Full Text] [Related]
5. [Hallucinogen-induced psychological disorders]. Hermle L, Kovar KA, Hewer W, Ruchsow M. Fortschr Neurol Psychiatr; 2008 Jun 11; 76(6):334-42. PubMed ID: 18512184 [Abstract] [Full Text] [Related]
9. Some aspects of the current drug scene with emphasis on drugs in use by adolescents. Louria DB. Pediatrics; 1968 Dec 11; 42(6):904-11. PubMed ID: 5726384 [No Abstract] [Full Text] [Related]
10. A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts. Kleinman JE, Gillin JC, Wyatt RJ. Schizophr Bull; 1977 Dec 11; 3(4):560-86. PubMed ID: 271353 [No Abstract] [Full Text] [Related]
11. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'. Koerner J, Appel JB. Psychopharmacology (Berl); 1982 Dec 11; 76(2):130-5. PubMed ID: 6805022 [Abstract] [Full Text] [Related]
12. Mescaline, LSD, psilocybin, and personality change. UNGER SM. Psychiatry; 1963 May 11; 26():111-25. PubMed ID: 13995386 [No Abstract] [Full Text] [Related]
13. [RESEARCH CONCERNING THE PHARMACOLOGIC CHARACTERIZATION AND DIFFERENTIATION OF HALLUCINOGENIC DRUGS (INDOLE DERIVATES AND MESCALINE, NALORPHINE, CENTRAL ANTICHOLINERGIC AGENTS, PHENCYCLIDINE)]. JACOB J, LAFILLE C, LOISEAU G, ECHINARD-GARIN P, BARTHELEMY C. Encephale; 1964 May 11; 53():520-35. PubMed ID: 14222727 [No Abstract] [Full Text] [Related]
14. [Toxic ecstasy]. Leuner H. Bibl Psychiatr Neurol; 1968 May 11; 134():73-114. PubMed ID: 5753775 [No Abstract] [Full Text] [Related]
15. Treatment of acute hallucinogenic drug toxicity: specific pharmacological intervention. Consroe PF. Bull Natl Clgh Poison Control Cent; 1973 May 11; ():1-7. PubMed ID: 4571809 [No Abstract] [Full Text] [Related]
16. Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases. Licht CL, Christoffersen M, Okholm M, Damgaard L, Fink-Jensen A, Knudsen GM, Erritzoe D. Hum Psychopharmacol; 2012 Jul 11; 27(4):352-63. PubMed ID: 22696164 [Abstract] [Full Text] [Related]